Scopus BioPharma (SCPS) Stock Chart & Stock Price History $0.0003 0.00 (0.00%) As of 08/14/2025 09:30 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock Scopus BioPharma Stock Price Performance The Scopus BioPharma (SCPS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 50.00%, with a year-to-date return of 0.00%. In the past month, the stock has remained steady at 0.00%, reflecting recent market activity. As of the latest close, Scopus BioPharma traded at $0.00 with a market cap of $13 thousand and volume of 1,668 shares. Receive SCPS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Scopus BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month PerformanceN/A3 Month Performance0.00%Year-To-Date Performance0.00%1 Year Performance+50.00% SCPS Stock Chart for Friday, August, 15, 2025 SCPS Chart by TradingView Scopus BioPharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$0.00$0.00$0.00$0.001,668 shs$13,000.0008/14/2025$0.00$0.00$0.00$0.001,668 shs$13,000.0008/13/2025$0.00$0.00$0.00$0.004,100 shs$13,000.0008/12/2025$0.00$0.00$0.00$0.004,100 shs$13,000.0008/08/2025$0.00$0.00$0.00$0.001,000 shs$13,000.0008/07/2025$0.00$0.00$0.00$0.001,000 shs$13,000.0008/06/2025$0.00$0.00$0.00$0.0013 shs$13,000.0008/01/2025$0.00$0.00$0.00$0.00100 shs$13,000.0007/31/2025$0.00$0.00$0.00$0.00100 shs$13,000.0007/24/2025$0.00$0.00$0.00$0.00179 shs$13,000.00 Get the Latest News and Ratings for SCPS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Scopus BioPharma and its competitors with MarketBeat's FREE daily newsletter. 07/23/2025$0.00$0.00$0.00$0.00179 shs$13,000.0007/22/2025$0.00$0.00$0.00$0.00688 shs$13,000.0007/21/2025$0.00$0.00$0.00$0.00688 shs$13,000.0007/18/2025$0.00$0.00$0.00$0.0010 shs$13,000.0007/17/2025$0.00$0.00$0.00$0.00600 shs$13,000.0007/16/2025$0.00$0.00$0.00$0.00600 shs$13,000.0007/14/2025$0.00$0.00$0.00$0.001,340 shs$13,000.00 Related Companies Navidea Biopharmaceuticals Stock Chart Smart for Life Stock Chart Syros Pharmaceuticals Stock Chart Virpax Pharmaceuticals Stock Chart Evelo Biosciences Stock Chart Comera Life Sciences Stock Chart Genocea Biosciences Stock Chart Genocea Biosciences Stock Chart Aridis Pharmaceuticals Stock Chart Calithera Biosciences Stock Chart Receive SCPS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Scopus BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SCPS) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scopus BioPharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Scopus BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access